Skip to main content
Log in

GDNF

A novel factor with therapeutic potential for neurodegenerative disorders

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

The identification of novel factors that promote neuronal survival could have profound effects on developing new therapeutics for neurodegenerative disorders. Glial cell line-derived neurotrophic factor (GDNF) is a novel protein purified and cloned based on its marked ability to promote dopaminergic neuronal function. GDNF, now known to be the first identified member of a family of factors, signals through the previously known receptor tyrosine kinase, Ret. Unlike most ligands for receptor tyrosine kinases, GDNF does not bind and activate Ret directly, but requires the presence of GPI-linked coreceptors. There are several coreceptors with differing affinities for the GDNF family members. The profile of coreceptors in a cell may determine which factor preferentially activates Ret. In vivo differences in localization of the GDNF family members, its coreceptors and Ret suggest this ligand/receptor interaction has extensive and multiple functions in the CNS as well as in peripheral tissues.

GDNF promotes survival of several neuronal populations both in vitro and in vivo. Dopaminergic neuronal survival and function are preserved by GDNF in vivo when challenged by the toxins MPTP and 6-hydroxydopamine. Furthermore, GDNF improves the symptoms of pharmacologically induced Parkinson's disease in monkeys. Several motor neuron populations isolated in vitro are also rescued by GDNF. In vivo, GDNF protects these neurons from programmed cell death associated with development and death induced by neuronal transection. These experiments suggest that GDNF may provide significant therapeutic opportunities in several neurodegenerative disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lin, L.-F., Doherty, D. H., Lile, J. D., Bektesh, S. and Collins, F. (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.Science 260, 1130–1132.

    Article  PubMed  CAS  Google Scholar 

  2. McDonald, N. Q. and Hendrickson, W. A. (1993) A structural superfamily of growth factors containing a cystine knot motif.Cell 73, 421–424.

    Article  PubMed  CAS  Google Scholar 

  3. Kingsley, D. M. (1994) The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms.Genes Dev 8, 133–146.

    Article  PubMed  CAS  Google Scholar 

  4. Santoro, M., Carlomagno, F., Hay, I. D., Herrmann, M. A., Grieco, M., Melillo, R., Pierotti, M. A., Bongarzone, I., Della Porta, G., Berger, N., et al. (1992) Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.J. Clin. Invest. 89, 1517–1522.

    PubMed  CAS  Google Scholar 

  5. Mulligan, L. M., Kwok, J. B., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S., Moore, J. K., Papi, L., et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.Nature 363, 458–460.

    Article  PubMed  CAS  Google Scholar 

  6. Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F., Goodfellow, P. and Wells, S. A. J. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.Hum. Mol. Genet. 2, 851–856.

    Article  PubMed  CAS  Google Scholar 

  7. Carlson, K. M., Dou, S., Chi, D., Scavarda, N., Toshima, K., Jackson, C. E., Wells, S. A. J., Goodfellow, P. J. and Donis-Keller, H. (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.Proc. Natl. Acad. Sci. USA 91, 1579–1583.

    Article  PubMed  CAS  Google Scholar 

  8. Carlomagno, F., De Vita, G., Berlingieri, M. T., De Franciscis, V., Melillo, R. M., Colantuoni, V., Kraus, M. H., Di Fiore, P. P., Fusco, A. and Santoro, M. (1996) Molecular heterogeneity of RET loss of function in Hirschsprung's disease.EMBO J. 15, 2717–2725.

    PubMed  CAS  Google Scholar 

  9. Edery, P., Lyonnet, S., Mulligan, L. M., Pelet, A., Dow, E., Abel, L., Holder, S., Nihoul-Fekete, C., Ponder, B. A. and Munnich, A. (1994) Mutations of the RET proto-oncogene in Hirschsprung's disease.Nature 367, 378–380.

    Article  PubMed  CAS  Google Scholar 

  10. Romeo, G., Ronchetto, P., Luo, Y., Barone, V., Seri, M., Ceccherini, I., Pasini, B., Bocciardi, R., Lerone, M. and Kaariainen, H. (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.Nature 367, 377–378.

    Article  PubMed  CAS  Google Scholar 

  11. Rescorla, F. J., Morrison, A. M., Engles, D., West, K. W. and Grosfeld, J. L. (1992) Hirschsprung's disease. Evaluation of mortality and long-term function in 260 cases.Arch. Surg. 127, 934–941.

    PubMed  CAS  Google Scholar 

  12. Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F. and Pachnis, V. (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret.Nature 367, 380–383.

    Article  PubMed  CAS  Google Scholar 

  13. Pachnis, V., Mankoo, B. and Costantini, F. (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis.Development 119, 1005–1017.

    PubMed  CAS  Google Scholar 

  14. Saxen L. (1987)Organogenesis of the Kidney. Cambridge University Press, Cambridge, UK.

    Google Scholar 

  15. Lechner, M. S. and Dressler, G. R. (1997) The molecular basis of embryonic kidney development.Mech. Dev. 62, 105–120.

    Article  PubMed  CAS  Google Scholar 

  16. Sariola, H. and Sainio, K. (1997) The tip-top branching ureter.Curr. Opin. Cell. Biol. 9, 877–884.

    Article  PubMed  CAS  Google Scholar 

  17. Kearns, C. M. and Gash, D. M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.Brain Res. 672, 104–111.

    Article  PubMed  CAS  Google Scholar 

  18. Li, L., Wu, W., Lin, L.-F., Lei, M., Oppenheim, R. W. and Houenou, L. J. (1995) Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor.Proc. Natl. Acad. Sci. USA 92, 9771–9775.

    Article  PubMed  CAS  Google Scholar 

  19. Henderson, C. E., Phillips, H. S., Pollock, R. A., Davies, A. M., Lemeulle, C., Armanini, M., Simpson, L. C., Moffet B., Vandlen, R. A., Koliatsos, V. E., et al. (1994) GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle.Science 266, 1062–1064.

    Article  PubMed  CAS  Google Scholar 

  20. Beck, K. D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R. A., Rosenthal, A. and Hefti, F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain.Nature 373, 339–341.

    Article  PubMed  CAS  Google Scholar 

  21. Oppenheim, R. W., Houenou, L. J., Johnson, J. E., Lin, L.-F. H., Li, L., Lo, A. C., Newsome, A. L., Prevette, D. M. and Wang, S. (1995) Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF.Nature 373, 344–346.

    Article  PubMed  CAS  Google Scholar 

  22. Yan, Q., Matheson, C. and Lopez, O. T. (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons.Nature 373, 341–344.

    Article  PubMed  CAS  Google Scholar 

  23. Zurn, A. D., Winkel, L., Menoud, A., Djabali, K. and Aebischer, P. (1996) Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro.J. Neurosci. Res. 44, 133–141.

    Article  PubMed  CAS  Google Scholar 

  24. Gash, D. M., Zhang, Z. M., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) Functional recovery in parkinsonian monkeys treated with GDNF.Nature 380, 252–255.

    Article  PubMed  CAS  Google Scholar 

  25. Hoffer, B. J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L. H. and Gerhardt, G. A. (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo.Neurosci. Lett. 182, 107–111.

    Article  PubMed  CAS  Google Scholar 

  26. Suvanto, P., Hiltunen, J. O., Arumäe, U., Moshnyakov, M., Sariola, H., Sainio, K. and Saarma, M. (1996) Localization of glial cell line-derived neurotrophic factor (GDNF) mRNA in embryonic rat by in situ hybridization.Eur. J. Neurosci. 8, 816–822.

    Article  PubMed  CAS  Google Scholar 

  27. Sánchez, M. P., Silos-Santiago, I., Frisén, J., He, B., Lira, S. A. and Barbacid, M. (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF.Nature 382, 70–73.

    Article  PubMed  Google Scholar 

  28. Pichel, J. G., Shen, L. Y., Sheng, H. Z., Granholm, A. C., Drago, J., Grinberg, A., Lee, E. J., Huang, S. P., Saarma, M., Hoffer, B. J., et al. (1996) Defects in enteric innervation and kidney development in mice lacking GDNF.Nature 382, 73–76.

    Article  PubMed  CAS  Google Scholar 

  29. Moore, M. W., Klein, R. D., Fariñas, I., Sauer, H., Armanini, M., Phillips, H., Reichardt, L. F., Ryan, A. M., Carver-Moore, K. and Rosenthal, A. (1996) Renal and neuronal abnormalities in mice lacking GDNF.Nature 382, 76–79.

    Article  PubMed  CAS  Google Scholar 

  30. Tomac, A., Lindqvist, E., Lin, L.-F.H., Ögren, S. O., Young, D., Hoffer, B. J. and Olson, L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo.Nature 373, 335–339.

    Article  PubMed  CAS  Google Scholar 

  31. Arenas, E., Trupp, M., Akerud, P., and Ibáñez, C. F. (1995) GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo.Neuron 15, 1465–1473.

    Article  PubMed  CAS  Google Scholar 

  32. Durbec, P., Marcos-Gutierrez, C. V., Kilkenny, C., Grigoriou, M., Wartiovaara, K., Suvanto, P., Smith, D., Ponder, B., Costantini, F., Saarma, M., et al. (1996) GDNF signalling through the Ret receptor tyrosine kinase.Nature 381, 789–793.

    Article  PubMed  CAS  Google Scholar 

  33. Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A. S., Sieber, B. A., Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V., Arumäe, U., et al. (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene.Nature 381, 785–789.

    Article  PubMed  CAS  Google Scholar 

  34. Vega, Q. C., Worby, C. A., Lechner, M. S., Dixon, J. E. and Dressler, G. R. (1996) Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis.Proc Natl Acad Sci USA 93, 10,657–10,661.

    Article  CAS  Google Scholar 

  35. Worby, C. A., Vega, Q. C., Zhao, Y., Chao, H. H. J., Seasholtz, A. F. and Dixon, J. E. (1996) Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase.J. Biol. Chem. 271, 23,619–23,622.

    CAS  Google Scholar 

  36. Sainio, K., Suvanto, P., Davies, J., Wartiovaara, J., Wartiovaara, K., Saarma, M., Arumae, U., Meng, X., Lindahl, M., Pachnis, V., et al. (1997) Glial-cell-line-derived neurotrophic factor is required for bud initiation from the ureteric epithelium.Development 124, 4077–4087.

    PubMed  CAS  Google Scholar 

  37. Jing, S. Q., Wen, D. Z., Yu, Y. B., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., et al. (1996) GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF.Cell 85, 1113–1124.

    Article  PubMed  CAS  Google Scholar 

  38. Treanor, J. J. S., Goodman, L., De Sauvage, F., Stone, D. M., Poulsen, K. T., Beck, C. D., Gray, C., Armanini, M. P., Pollock, R. A., Hefti, F., et al. (1996) Characterization of a multicomponent receptor for GDNF.Nature 382, 80–83.

    Article  PubMed  CAS  Google Scholar 

  39. Baloh, R. H., Tansey, M. G., Golden, J. P., Creedon, D. J., Heuckeroth, R. O., Keck, C. L., Zimonjic, D. B., Popescu, N. C., Johnson, E. M. J. and Milbrandt, J. (1997) TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret.Neuron 18, 793–802.

    Article  PubMed  CAS  Google Scholar 

  40. Ip, N. Y. and Yancopoulos, G. D. (1996) The neurotrophins and CNTF: Two families of collaborative neurotrophic factors.Annu. Rev. Neurosci. 19, 491–515.

    Article  PubMed  CAS  Google Scholar 

  41. Klein, R. D., Sherman, D. P., Henderson CE, Ho, W. H., Stone, D., Bennett, G. L., Moffat, B., Vandlen, R. Simmons, L., Gu, Q., Hongo, J. A., et al. (1997) A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor.Nature 387, 717–721.

    Article  PubMed  CAS  Google Scholar 

  42. Kotzbauer, P. T., Lampe, P. A., Heuckeroth, R. O., Golden, J. P., Creedon, D. J., Johnson, E. M. and Milbrandt, J. (1996) Neurturin, a relative of glial-cell-line-derived neurotrophic factor.Nature 384, 467–470.

    Article  PubMed  CAS  Google Scholar 

  43. Milbrandt, J., de Sauvage, F. J., Fahrner, T. J., Baloh, R. H., Leitner, M. L., Tansey, M. G., Lampe, P. A., Heuckeroth, R. O., Kotzbauer, P. T., Simburger, K. S., et al. (1998) Persephin, a novel neurotrophic factor related to GDNF and neurturin.Neuron 20, 245–253.

    Article  PubMed  CAS  Google Scholar 

  44. Enokido, Y., De Sauvage, F., Hongo, J., Ninkina, N., Rosenthal, A., Buchman, V. L., and Davies, A. M. (1998) GFRα-4 and the tyrosine kinase Ret form a functional receptor complex for persephin.Curr. Biol. 8, 1019–1022.

    Article  PubMed  CAS  Google Scholar 

  45. Suvanto, P., Wartiovaara, K., Lindahl, M., Arumae, U., Moshnyakov, M., Horelli-Kuitunen, N., Airaksinen, M., Palotie, A., Sariola, H. and Saarma, M. (1997) Cloning, mRNA distribution and chromosomal localisation of the gene for human glial cell line-derived neurotrophic factor receptor beta, a homologue to GDNFR-alpha.Hum. Mol. Genet. 6, 1267–1273.

    Article  PubMed  CAS  Google Scholar 

  46. Buj-Bello, A., Adu, J., Pinon, L. G., Horton, A., Thompson, J., Rosenthal, A., Chinchetru, M., Buchman, V. L. and Davies, A. M. (1997) Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase.Nature 387, 721–724.

    Article  PubMed  CAS  Google Scholar 

  47. Widenfalk, J., Nosrat, C., Tomac, A., Westphal, H., Hoffer, B. and Olson, L. (1997) Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-β), novel proteins related to GDNF and GDNFR-α with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs.J. Neurosci. 17, 8506–8519.

    PubMed  CAS  Google Scholar 

  48. Sanicola, M., Hession, C., Worley, D., Carmillo, P., Ehrenfels, C., Walus, L., Robinson, S., Jaworski, G., Wei, H., Tizard, R., et al. (1997) Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins.Proc. Natl. Acad. Sci. USA 94, 6238–6243.

    Article  PubMed  CAS  Google Scholar 

  49. Trupp, M., Raynoschek, C., Belluardo, N. and Ibáñez, C. F. (1998) Multiple GPI-anchored receptors control GDNF-dependent and independent activation of the c-ret receptor tyrosine kinase.Mol. Cell. Neurosci. 11, 47–63.

    Article  PubMed  CAS  Google Scholar 

  50. Worby, C. A., Vega, Q. C., Chao, H. H. J., Seasholtz, A. F., Thompson, R. C. and Dixon, J. E. (1998) Identification and characterization of GFRalpha-3, a novel co-receptor belonging to the glial cell line-derived neurotrophic receptor family.J. Biol. Chem. 273, 3502–3508.

    Article  PubMed  CAS  Google Scholar 

  51. Jing, S., Yu, Y., Fang, M., Hu, Z., Holst, P. L., Boone, T., Delaney, J., Schultz, H., Zhou, R. and Fox, G. M. (1997) GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family.J. Biol. Chem. 272, 33,111–33,117.

    CAS  Google Scholar 

  52. Naveilhan, P., Baudet, C., Mikaels, A., Shen, L., Westphal, H. and Ernfors, P. (1998) Expression and regulation of GFRalpha3, a glial cell line-derived neurotrophic factor family receptor.Proc. Natl. Acad. Sci. USA 95, 1295–1300.

    Article  PubMed  CAS  Google Scholar 

  53. Thompson, J., Doxakis, E., Pinon, L. G. P., Strachan, P., Buj-Bello, A., Wyatt, S., Buchman, V. L., and Davies, A. M. (1998) GFRα-4, a new GDNF family receptor.Mol. Cell Neurol. 11, 117–126.

    Article  CAS  Google Scholar 

  54. Trupp, M., Belluardo, N., Funakoshi, H. and Ibáñez, C. F. (1997) Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS.J. Neurosci. 17, 3554–3567.

    PubMed  CAS  Google Scholar 

  55. Trupp, M., Rydén, M., Jörnvall, H., Funakoshi, H., Timmusk, T., Arenas, E. and Ibáñez, C. F. (1995) Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons.J. Cell Biol. 130, 137–148.

    Article  PubMed  CAS  Google Scholar 

  56. Granholm, A. C. E., Srivastava, N., Mott, J. L., Henry, M., Westphal, H., Pichel, J. G., Shen, L. Y. and Hoffer, B. J. (1997) Morphological alterations in the peripheral and central nervous systems of mice lacking glial cell line-derived neurotrophic factor (GDNF): Immunohistochemical studies.J. Neurosci. 17, 1168–1178.

    PubMed  CAS  Google Scholar 

  57. Tsuzuki, T., Takahashi, M., Asai, N., Iwashita, T., Matsuyama, M. and Asai, J. (1995) Spatial and temporal expression of theret proto-oncogene product in embryonic, infant and adult rat tissues.Oncogene 10, 191–198.

    PubMed  CAS  Google Scholar 

  58. Robertson, K. and Mason, I. (1995) Expression of ret in the chicken embryo suggests roles in regionalisation of the vagal neural tube and somites and in development of multiple neural crest and placodal lineages.Mech. Dev. 53, 329–344.

    Article  PubMed  CAS  Google Scholar 

  59. Marcos-Gutiérrez, C. V., Wilson, S. W., Holder, N. and Pachnis, V. (1997) The zebrafish homologue of the ret receptor and its pattern of expression during embryogenesis.Oncogene 14, 879–889.

    Article  PubMed  Google Scholar 

  60. Nosrat, C. A., Tomac, A., Hoffer, B. J. and Olson, L. (1997) Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs.Exp. Brain Res. 115, 410–422.

    Article  PubMed  CAS  Google Scholar 

  61. Ylikoski, J., Pirvola U, Virkkala J. et al. (1998) Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma.Hear. Res. 124, 17–26.

    Article  PubMed  CAS  Google Scholar 

  62. Naveilhan, P., ElShamy, W. M. and Ernfors, P. (1997) Differential regulation of mRNAs for GDNF and its receptors Ret and GDNFR alpha after sciatic nerve lesion in the mouse.Eur. J. Neurosci. 9, 1450–1460.

    Article  PubMed  CAS  Google Scholar 

  63. Nakamura, M., Ohta, K., Hirokawa, K., Fukushima, M., Uchino, M., Ando, M. and Tanaka, H. (1996) Developmental and denervation changes in c-ret proto-oncogene expression in chick motoneurons.Brain Res. Mol. Brain Res. 39, 1–11.

    Article  PubMed  CAS  Google Scholar 

  64. Clarkson, E. D., Zawada, W. M. and Freed, C. R. (1995) GDNF reduces apoptosis in dopaminergic neurons in vitro.Neuro Report 7, 145–149.

    CAS  Google Scholar 

  65. Hou, J. G., Lin, L. f. and Mytilineou, C. (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium.J. Neurochem. 66, 74–82.

    Article  PubMed  CAS  Google Scholar 

  66. Buj-Bello, A., Buchman, V. L., Horton, A., Rosenthal, A. and Davies, A. M. (1995) GDNF is an age-specific survival factor for sensory and autonomic neurons.Neuron 15, 821–828.

    Article  PubMed  CAS  Google Scholar 

  67. Pycock, C. J. (1980) Turning behavior in animals.Neuroscience 5, 461–514.

    Article  PubMed  CAS  Google Scholar 

  68. Tseng, J. L., Baetge, E. E., Zurn, A. D. and Aebischer, P. (1997) GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine.J. Neurosci. 17, 325–333.

    PubMed  CAS  Google Scholar 

  69. Schwarting, R. K. and Huston, J. P. (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments.Prog. Neurobiol. 50, 275–331.

    Article  PubMed  CAS  Google Scholar 

  70. Bowenkamp, K. E., Hoffman, A. F., Gerhardt, G. A., Henry, M. A., Biddle, P. T., Hoffer, B. J. and Granholm, A. C. E. (1995) Blial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.J. Comp. Neurol. 355, 479–489.

    Article  PubMed  CAS  Google Scholar 

  71. Sauer, H. and Oertel, W. H. (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.Neuroscience 59, 401–415.

    Article  PubMed  CAS  Google Scholar 

  72. Sauer, H., Rosenblad, C. and Bjorklund, A. (1997) Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion.Proc. Natl. Acad. Sci. USA 92, 8935–8939.

    Article  Google Scholar 

  73. Choi-Lundberg, D. L., Lin, Q., Chang, Y. N., Chiang, Y. L., Hay, C. M., Mohajeri, H., Davidson, B. L. and Bohn, M. C. (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy.Science 275, 838–841.

    Article  PubMed  CAS  Google Scholar 

  74. Schapira, A. H. (1992) MPTP and other Parkinson-inducing agents.Curr. Opin. Neurol. Neurosurg. 5, 396–400.

    PubMed  CAS  Google Scholar 

  75. Zhang, Z., Miyoshi, Y., Lapchak, P. A., Collins, F., Hilt, D., Lebel, C., Kryscio, R. and Gash, D. M. (1997) Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys.J. Pharmacol. Exp. Ther. 282, 1396–1401.

    PubMed  CAS  Google Scholar 

  76. Matheson, C. R., Wang, J., Collins, F. D. and Yan, Q. (1997) Long-term survival effects of GDNF on neonatal rat facial motoneurons after axotomy.NeuroReport 8, 1739–1742.

    Article  PubMed  CAS  Google Scholar 

  77. Gimenez y Ribotta, M., Revah, F., Pradier, L., Loquet, I., Mallet, J. and Privat, A. (1997) Prevention of motoneuron death by adenovirus mediated neurotrophic factors.J. Neurosci. Res. 48, 281–285.

    Article  PubMed  CAS  Google Scholar 

  78. Baumgartner, B. J. and Shine, H. D. (1997) Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population.J. Neurosci. 17, 6504–6511.

    PubMed  CAS  Google Scholar 

  79. Schmalbruch, H., Jensen, H. J., Bjaerg, M., Kamieniecka, Z. and Kurland, L. (1991) A new mouse mutant with progressive motor neuronopathy.J. Neuropathol. Exp. Neurol. 50, 192–204.

    Article  PubMed  CAS  Google Scholar 

  80. Sendtner, M., Schmalbruch, H., Stockli, K. A., Carroll, P., Kreutzberg, G. W. and Thoenen, H. (1992) Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive metor neuronopathy.Nature 358, 502–504.

    Article  PubMed  CAS  Google Scholar 

  81. Sagot, Y., Tan, S. A., Hammang, J. P., Aebischer, P. and Kato, A. C. (1996) GDNF slows loss of motoneurons but not axonal degeneration or premature death ofpmn/pmn mice.J. Neurosci. 16, 2335–2341.

    PubMed  CAS  Google Scholar 

  82. Batchelor, P. E., Armstrong, D. M., Blaker, S. N. and Gage, F. H. (1989) Nerve growth factor receptor and choline acetyltransferase colocalization in neurons within the rat forebrain: Response to fimbria-fornix transection.J. Comp. Neurol. 284, 187–204.

    Article  PubMed  CAS  Google Scholar 

  83. Sofroniew, M. V., Cooper, J. D., Svendson, C. N., Crossman, P., Ip, N. Y., Lindsay, R. M., Zafra, F. and Lindholm, D. (1993) Atrophy but not death of adult septal cholinergic neurons after ablation of target capacity to produce mRNAs for NGF, BDNF, and NT3.J. Neurosci. 13, 5263–5276.

    PubMed  CAS  Google Scholar 

  84. Williams, L. R., Inouye, G., Cummins, V. and Pelleymounter, M. A. (1996) Glial cell linederived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: Dose-response comparison to nerve growth factor and brain-derived neurotrophic factor.J. Pharmacol. Exp. Ther. 277, 1140–1151.

    PubMed  CAS  Google Scholar 

  85. Houenou, L. J., Oppenheim, R. W., Li, L. X., Lo, A. C. and Prevette, D. (1996) Regulation of spinal motoneuron survival by GDNF during development and following injury.Cell Tissue Res. 286, 219–223.

    Article  PubMed  CAS  Google Scholar 

  86. Humpel, C., Hoffer, B., Stromberg, I., Bektesh, S., Collins, F. and Olson, L. (1994) Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation.Neuroscience 59, 791–795.

    Article  PubMed  CAS  Google Scholar 

  87. Olson, L., Nordberg, A., vonHolst, H., Backman, L., Ebendal, T., Alafuzoff, I., Amberla, K., Hartvig, P., Herlitz, A., Lija, A., et al. (1992) Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).J. Neural Transm. Park. Dis. Dement. Sect. 4, 79–95.

    Article  PubMed  CAS  Google Scholar 

  88. Olson, L., Backlund, E. O., Ebendal, T., Freedman, R., Hamberger, B., Hansson, P., Hoffer, B., Lindblom, U., Meyerson, B., Stromberg, I., et al. (1991) Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial.Arch. Neurol. 48, 373–378.

    PubMed  CAS  Google Scholar 

  89. Bilang-Bleuel, A., Revah, F., Colin, P., Locquet, I., Robert, J. J., Mallet, J. and Horellou, P. (1997) Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.Proc. Natl. Acad. Sci. USA 94, 8818–8823.

    Article  PubMed  CAS  Google Scholar 

  90. Winkler, C., Sauer, H., Lee, C. S. and Björklund, A. (1996) Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease.J. Neurosci. 16, 7206–7215.

    PubMed  CAS  Google Scholar 

  91. Dore, S., Kar, S., and Quiron, R. (1997) Rediscovering an old friend, IGF-1: potential use in the treatment of neurodegenerative disease.Trends Neurosci. 20, 326–331.

    Article  PubMed  CAS  Google Scholar 

  92. Lai, E. C., Felice, K. J., Festoff, B. W., Gawel, M. J., Gelinas, D. F., Kratz, R., Murphy, M. F., Natter, H. M., Norris, F. H. and Rudnicki, S. A. (1997) Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group.Neurology 49, 1621–1630.

    PubMed  CAS  Google Scholar 

  93. Borasio, G. D., Robberecht, W., Leigh, P. N., Emile, J., Guiloff, R. J., Jerusalem, F., Silani, V., Vos, P. E., Wokke, J. H., and Dobbins, T. (1998) A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group.Neurology 51, 583–586.

    PubMed  CAS  Google Scholar 

  94. ALS CNTF Treatment Study Group (1996) A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis.Neurology 46, 1244–1249.

    Google Scholar 

  95. GFRα Nomenclature Committee (1997) Nomenclature of GPI-linked receptors for the GDNF ligand family.Neuron 19, 485.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walton, K.M. GDNF. Mol Neurobiol 19, 43–59 (1999). https://doi.org/10.1007/BF02741377

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02741377

Keywords

Navigation